Haematology and Immunoglobulin Treatments       

Haematology and Immunoglobulin Treatments        image

Home » FOI request log » Haematology and Immunoglobulin Treatments       

FOI REFERENCE: 24203   FOI DATE: 3rd July 2024     

Q1. In the past 3 months, how many patients have received the following treatments (for any disease): 

  • Berinert (Human C1-esterase inhibitor)         * Patients     
  • Cinryze (Human C1-esterase inhibitor)          0 Patients                    
  • Firazyr (Icatibant)                                           0 Patients                             
  • Icatibant – any brand except Firazyr               0 Patients            
  • Orladeyo (Berotralstat)                                   0 Patients         
  • Ruconest (Recombinant human C1-esterase inhibitor)         0 Patients  
  • Takhzyro (Lanadelumab)                               0 Patients        

Q2. In the past 3 months, how many patients have received the following immunoglobulin treatments (for any disease): 

  • Cutaquig                                                         0 Patients
  • Cuvitru                                                            0 Patients
  • Gammagard                                                   0 Patients
  • Gammanorm                                                  0 Patients
  • Hizentra                                                          0 Patients
  • Hyqvia                                                            0 Patients
  • Intratect                                                          14 Patients
  • Iqymune                                                         0 Patients
  • Kiovig                                                             0 Patients
  • Privigen                                                          28 Patients
  • Octagam                                                         * Patients
  • Panzyga                                                         0 Patients
  • Subgam                                                          0 Patients
  • Any other normal immunoglobulin                 5 (FlebogammaDif)   

*This relates to low numbers between 1 and 4. Under section 40 (ii) of the Freedom of Information Act 2000, statistically low numbers that potentially identify personal data are required to be withheld because of the Trusts obligation to protect personal data under the Data Protection Act 2018